Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

1.3K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.3K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

715
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
715
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

412
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
412
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

4.8K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
4.8K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

271
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
271

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Outcomes and Prognostic Factors of Percutaneous Transhepatic Biliary Drainage in Malignant Biliary Obstruction: A Retrospective Study of 383 Patients.

Nigerian journal of clinical practice·2026
Same author

Radiology of Endometrial Cancer Receiving Adjuvant Radiotherapy.

Nigerian journal of clinical practice·2026
Same author

Comprehensive investigation into the endothelium in Legg-Calvé-Perthes with clinical, molecular, and histopathological examinations reveals arteriolar wall thickening and proliferative synovitis: A preliminary report.

Acta orthopaedica Belgica·2026
Same author

Radiologic Follow-up of Vascular Structures in Gastric Cancer Patients Receiving Adjuvant Radiotherapy.

Nigerian journal of clinical practice·2025
Same author

Magnetic Resonance Imaging Assessment of Rectal and Vascular Changes Following Radiotherapy in Prostate Cancer Patients.

Nigerian journal of clinical practice·2025
Same author

Photosynthesis and hydrogen energy for sustainability: harnessing the sun for a greener future.

Photosynthetica·2024

Related Experiment Video

Updated: Sep 19, 2025

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

386

INVESTIGATION OF ADHERENCE TO POSTPARTUM DIABETES SCREENING RECOMMENDATIONS FOR PATIENTS WITH GESTATIONAL DIABETES,

G Yilmaz1, S K Akkaya1, M I Kaya1

  • 1Department of Obstetrics and Gynecology, Ministry of Health, Ankara City Hospital, Ankara, Republic of Turkey.

Acta Endocrinologica (Bucharest, Romania : 2005)
|June 18, 2025
PubMed
Summary
This summary is machine-generated.

Postpartum diabetes screening adherence is low in women with gestational diabetes, with most not screening at all. Improved education during pregnancy and postpartum is crucial for high-risk women.

Keywords:
AdherenceGestational Diabetes MellitusGlucose Tolerance TestPostpartum glucose testingScreening

More Related Videos

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
06:11

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring

Published on: May 17, 2024

772
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.9K

Related Experiment Videos

Last Updated: Sep 19, 2025

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

386
Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
06:11

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring

Published on: May 17, 2024

772
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.9K

Area of Science:

  • Endocrinology
  • Public Health
  • Obstetrics & Gynecology

Background:

  • Gestational diabetes mellitus (GDM) increases the risk of type 2 diabetes post-pregnancy.
  • Postpartum screening is vital for early detection and management of diabetes after GDM.

Purpose of the Study:

  • To evaluate adherence to postpartum diabetes screening in women with a history of GDM in Turkey.
  • To identify reasons for non-compliance with recommended screening protocols.

Main Methods:

  • A cross-sectional study involving 783 postpartum women with GDM.
  • Participants were grouped based on screening behavior: no screening, fasting plasma glucose (FPG)/HbA1c only, or oral glucose tolerance test (OGTT) only.
  • Data collected included demographics and reasons for non-compliance.

Main Results:

  • Only 3.45% of women adhered to recommended screening; 55.81% underwent no screening.
  • Higher adherence was observed in primigravid women.
  • Significant differences in adherence were linked to education, GDM treatment, and information received (p<0.001).
  • Normal postpartum FPG values were the primary reason for non-compliance.

Conclusions:

  • Low adherence to postpartum diabetes screening necessitates improved patient education.
  • Enhanced information provision during pregnancy and postpartum hospital stays is critical for high-risk GDM patients.
  • Targeted interventions are needed to improve screening rates and long-term diabetes prevention.